• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION STERLING; CATHETER, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION STERLING; CATHETER, PERCUTANEOUS Back to Search Results
Model Number H74939032401010
Medical Device Problem Codes Difficult to Remove (1528); Failure to Deflate (4060)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/27/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that balloon deflation failure occurred.A 4.0mmx100mmx135cm (4f) sterling balloon catheter was advanced for dilation.During the procedure, the balloon was unable to deflate and a great deal of difficulties of removing it from the patient were encountered.
 
Event or Problem Description
It was reported that balloon deflation failure occurred.A 4.0mmx100mmx135cm (4f) sterling balloon catheter was advanced for dilation.During the procedure, the balloon was unable to deflate and a great deal of difficulties of removing it from the patient were encountered.It was further reported that the sterling balloon catheter was selected for use in the distal superficial femoral artery.The target lesion was 60-70% stenosed with mild calcification and no tortuosity.There was difficulty removing the balloon and it was ultimately removed inflated through the long 6fr sheath.A new sterling balloon was used to complete the procedure.Good clinical results were noted as the procedure outcome, and the patient was discharged the next day as planned.
 
Additional Manufacturer Narrative
Device eval by mfr: the device was received and analysis completed.The returned product consisted of a sterling balloon catheter.The outer shaft, inner shaft, balloon and tip were visually and microscopically examined.Visual examination revealed that the shaft is stretched 94.8cm from the hub.Microscopic examination revealed no additional damages.Inspection of the remainder of the device presented no other damage or irregularities.
 
Event or Problem Description
It was reported that balloon deflation failure occurred.A 4.0mmx100mmx135cm (4f) sterling balloon catheter was advanced for dilation.During the procedure, the balloon was unable to deflate and a great deal of difficulties of removing it from the patient were encountered.It was further reported that the sterling balloon catheter was selected for use in the distal superficial femoral artery.The target lesion was 60-70% stenosed with mild calcification and no tortuosity.There was difficulty removing the balloon and it was ultimately removed inflated through the long 6fr sheath.A new sterling balloon was used to complete the procedure.Good clinical results were noted as the procedure outcome, and the patient was discharged the next day as planned.
 
Additional Manufacturer Narrative
"udi related data quality updates only.This report is being filed as a correction in response to an fda request for the complete the unique identifier (udi) #." device eval by mfr: the device was received and analysis completed.The returned product consisted of a sterling balloon catheter.The outer shaft, inner shaft, balloon and tip were visually and microscopically examined.Visual examination revealed that the shaft is stretched 94.8cm from the hub.Microscopic examination revealed no additional damages.Inspection of the remainder of the device presented no other damage or irregularities.
 
Event or Problem Description
It was reported that balloon deflation failure occurred.A 4.0mmx100mmx135cm (4f) sterling balloon catheter was advanced for dilation.During the procedure, the balloon was unable to deflate and a great deal of difficulties of removing it from the patient were encountered.It was further reported that the sterling balloon catheter was selected for use in the distal superficial femoral artery.The target lesion was 60-70% stenosed with mild calcification and no tortuosity.There was difficulty removing the balloon and it was ultimately removed inflated through the long 6fr sheath.A new sterling balloon was used to complete the procedure.Good clinical results were noted as the procedure outcome, and the patient was discharged the next day as planned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERLING
Common Device Name
CATHETER, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18377721
Report Number2124215-2023-70156
Device Sequence Number15357760
Product Code DQY
UDI-Device Identifier08714729123507
UDI-Public(01)08714729123507(17)20260530(10)0031730217
Combination Product (Y/N)N
Initial Reporter CountryUK
PMA/510(K) Number
K053116
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 07/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/30/2026
Device Model NumberH74939032401010
Device Catalogue Number24700
Device Lot Number0031730217
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/28/2023
Supplement Date Received by Manufacturer12/27/2023
02/07/2024
07/09/2024
Initial Report FDA Received Date12/21/2023
Supplement Report FDA Received Date01/18/2024
03/01/2024
07/24/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/31/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-